Priority indications
- Rare diseases
- Neurological disorders
- Immunology
- Oncology
Our Portfolio
Indications
Modality
Modality
Evaluation
Structuring
Pre-incubation
Incubation
NewCo Serie A
Neuro
SME
SME
Immuno-onco
Biologics
Biologics
Rare disease
SME
SME
Immuno
Biologics
Biologics
Rare diseases
GT
GT
Oncology
GT
GT
Oncology
SME
SME
Rare diseases
SME
SME
Multiple - Modality
Biologics
Biologics
Rare diseases - Modality
Biologics
Biologics
THerapeutics AREAS FOCUS
Therapeutic Modalities
ANY therapeutic modalities, including SMEs, peptides, biologics, gene & cell therapy...
Platform technologies favored
Key topics of interest
- Novel targets
- Viral and non-viral delivery to CNS, muscle, kidney…
- In vivo cell therapies
- RNA therapeutics
- Synthetic lethality, PARPi resistance
- Protein targeted degradation
- Platform for directed evolution of proteins
- High-throughput phenotypical screens
Not Covered
- Infectious diseases, repurposing
- Standalone diagnostics
- Standalone medical devices
- Standalone software